Therefore, motivated by the compelling evidence, we hypothesized that the integration of pretreatment glucose (GLU) and CRP-to-albumin ratio (CAR) measurements, namely, the GLUCAR index, should provide improved predictive capabilities for the unavoidable tooth extractions in patients with LA-NPC undergoing definitive C-CRT. This evidence concerns the gene CRP and nasopharyngeal carcinoma.